Growth Metrics

Oncology Institute (TOI) Treasury Shares: 2020-2024

Historic Treasury Shares for Oncology Institute (TOI) over the last 2 years, with FY2024 value amounting to $1.0 million.

  • Oncology Institute's Treasury Shares rose 1861.52% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 1861.52%. This contributed to the annual value of $1.7 million for FY2024, which is 2033.83% down from last year.
  • Per Oncology Institute's latest filing, its Treasury Shares stood at $1.0 million for FY2024, which was down 0.0% from $1.0 million recorded in FY2023.
  • Oncology Institute's Treasury Shares' 5-year high stood at $2.2 million during FY2023, with a 5-year trough of $1.4 million in FY2020.
  • Over the past 5 years, Oncology Institute's median Treasury Shares value was $1.7 million (recorded in 2024), while the average stood at $1.8 million.
  • Data for Oncology Institute's Treasury Shares shows a peak YoY increase of 0.0% (in 2024) and a maximum YoY decrease of 0.0% (in 2024) over the last 5 years.
  • Annual analysis of 5 years shows Oncology Institute's Treasury Shares stood at $1.4 million in 2020, then rose by 15.21% to $1.6 million in 2021, then skyrocketed by 31.46% to $2.1 million in 2022, then rose by 3.32% to $2.2 million in 2023, then fell by 20.34% to $1.7 million in 2024.
  • Its Treasury Shares was $1.7 million in FY2024, compared to $2.2 million in FY2023 and $2.1 million in FY2022.